Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan
- PMID: 32351215
- DOI: 10.1016/j.apradiso.2020.109105
Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan
Abstract
Radiation therapy has an irreplaceable role in modern oncologic therapy, thanks to the advanced radiation techniques developed in recent decades. However, photon-resistant cases are sometimes encountered. Boron Neutron Capture Therapy (BNCT) is a highly selective radiotherapy technique due to the high tumor to tissue ratio of boronophenylalanine (BPA), the unique medication used for the BNCT treatment reaction. In this study, we report on three special patients with malignant brain tumors treated with BNCT.
Keywords: Boron Neutron Capture Therapy; Mismatch repair syndrome; Recurrent glioblastoma.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
